Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 70 of 107 for:    PHENYTOIN

HLA Screening in Reducing the Risk of Antiepileptic Drug-induced Cutaneous Adverse Reactions

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03184597
Recruitment Status : Recruiting
First Posted : June 12, 2017
Last Update Posted : September 5, 2018
Sponsor:
Collaborators:
Guangzhou First People's Hospital
West China Hospital
Guangdong Provincial People's Hospital
First Affiliated Hospital of Jinan University
Guangdong 999 Brain Hospital
First Affiliated Hospital, Sun Yat-Sen University
Wuhan Women and Children's Medical Center
First People's Hospital, Shunde China
Information provided by (Responsible Party):
Second Affiliated Hospital of Guangzhou Medical University

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : June 2021
Estimated Study Completion Date : June 2021
Publications: